Liposomal and Viral Vectors for Gene Therapy of the Central Nervous System

Publisher： Bentham Science Publishers

E-ISSN： 2212-5299|4|4|453-465

ISSN： 1568-007X

Source： Current Drug Targets-CNS & Neurological Disorders, Vol.4, Iss.4, 2005-08, pp. : 453-465

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gene Therapy Targeting in the Central Nervous System

By  

Current Gene Therapy, Vol. 3, Iss. 2, 2003-04 ,pp. : 127-145

Bentham Science Publishers

Access to resources Recommend Favorite

Gene Therapy-Mediated Modulation of Immune Processes in the Central Nervous System

By  

Current Pharmaceutical Design, Vol. 9, Iss. 24, 2003-09 ,pp. : 2002-2008

Bentham Science Publishers

Access to resources Recommend Favorite

Phosphonolipids as non-viral vectors for gene therapy

By Floch V.   Le Bolc'h G.   Gable-Guillaume C.   Le Bris N.   Yaouanc J.-J.   des Abbayes H.   Ferec C.   Clement J.-C.  

European Journal of Medicinal Chemistry, Vol. 33, Iss. 12, 1998-12 ,pp. : 923-934

Elsevier

Access to resources Recommend Favorite

Viral Vectors for Gene-Directed Enzyme Prodrug Therapy

By  

Current Gene Therapy, Vol. 6, Iss. 6, 2006-12 ,pp. : 647-670

Bentham Science Publishers

Access to resources Recommend Favorite

Viral Vectors for Cancer Gene Therapy: Viral Dissemination and Tumor Targeting

By  

Current Gene Therapy, Vol. 5, Iss. 1, 2005-02 ,pp. : 133-142

Bentham Science Publishers

Access to resources Recommend Favorite